CoChat

Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics

Open access
Naia, Luana, Carmo, Catarina, Campesan, Susanna, Fão, Lígia, Cotton, Victoria E., Valero, Jorge, Lopes, Carla, Rosenstock, Tatiana R., Giorgini, Flaviano, Rego, A. Cristina · 2021 · Free Radical Biology and Medicine
Cited by 75

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

SIRT3 is a major regulator of mitochondrial acetylome. Here we show that SIRT3 is neuroprotective in Huntington's disease (HD), a motor neurodegenerative disorder caused by an abnormal expansion of polyglutamines in the huntingtin protein (HTT). Protein and enzymatic analysis revealed that increased SIRT3 is a signature in several HD models, including human HD brain, which is regulated by oxidative species. While loss of SIRT3 further aggravated the oxidative phenotype, antioxidant treatment regularized SIRT3 levels. SIRT3 overexpression promoted the antioxidant effect in cells expressing mutant HTT, leading to enhanced mitochondrial function and balanced dynamics. Decreased Fis1 and Drp1 accumulation in mitochondria induced by SIRT3 expression favored mitochondrial elongation, while the SIRT3 activator ε-viniferin improved anterograde mitochondrial neurite transport, sustaining cell survival. Notably, SIRT3 fly-ortholog dSirt2 overexpression in HD flies ameliorated neurodegeneration and extended lifespan. These findings provide a link between oxidative stress and mitochondrial dysfunction hypotheses in HD and offer an opportunity for therapeutic development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.freeradbiomed.2020.11.031

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 46

  1. Scher, 2007, SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress, Genes Dev., 21, 920, 10.1101/gad.1527307 · DOI · Paper page
  2. Iwahara, 2012, SIRT3 functions in the nucleus in the control of stress-related gene expression, Mol. Cell Biol., 32, 5022, 10.1128/MCB.00822-12 · DOI · Paper page
  3. Schwer, 2002, The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase, J. Cell Biol., 158, 647, 10.1083/jcb.200205057 · DOI · Paper page
  4. Barger, 2017, Identification of tissue-specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics, Aging Cell, 16, 750, 10.1111/acel.12608 · DOI · Paper page
  5. Weir, 2012, CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease, PLoS One, 7, 10.1371/journal.pone.0048225 · DOI · Paper page
  6. Yang, 2016, Mitochondrial sirtuin network reveals dynamic SIRT3-dependent deacetylation in response to membrane depolarization, Cell, 167, 985, 10.1016/j.cell.2016.10.016 · DOI · Paper page
  7. Onyango, 2002, SIRT3, a human SIR2 homologue, is an NAD- dependent deacetylase localized to mitochondria, Proc. Natl. Acad. Sci., 99, 13653, 10.1073/pnas.222538099 · DOI · Paper page
  8. Cheng, 2015, Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges, Cell Metabol., 1
  9. Zhang, 2016, PGC-1α/ERRα-Sirt3 pathway regulates DAergic neuronal death by directly deacetylating SOD2 and ATP synthase β, Antioxidants Redox Signal., 24, 312, 10.1089/ars.2015.6403 · DOI · Paper page
  10. Beal, 1993, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci., 13, 4181, 10.1523/JNEUROSCI.13-10-04181.1993 · DOI · Paper page
  11. Naia, 2017, Comparative mitochondrial-based protective effects of resveratrol and nicotinamide in huntington's disease models, Mol. Neurobiol., 54, 10.1007/s12035-016-0048-3 · DOI
  12. Fu, 2012, trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease, J. Biol. Chem., 287, 24460, 10.1074/jbc.M112.382226 · DOI · Paper page
  13. Naia, 2018, Isolation and maintenance of striatal neurons, Bio Protocol., 8, 10.21769/BioProtoc.2823 · DOI
  14. Trettel, 2000, Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells, Hum. Mol. Genet., 9, 2799, 10.1093/hmg/9.19.2799 · DOI · Paper page
  15. Onofre, 2016, Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment, Sci. Rep., 6, 10.1038/srep28220 · DOI
  16. Ferreira, 2018, Assessing mitochondrial function in in vitro and ex vivo models of huntington's disease, 415, 10.1007/978-1-4939-7825-0_19 · DOI
  17. Dickinson, 2013, Preparation and use of MitoPY1 for imaging hydrogen peroxide in mitochondria of live cells, Nat. Protoc., 8, 1249, 10.1038/nprot.2013.064 · DOI · Paper page
  18. Rego, 2001, The mechanism of mitochondrial membrane potential retention following release of cytochrome c in apoptotic GT1-7 neural cells, Cell Death Differ., 8, 995, 10.1038/sj.cdd.4400916 · DOI
  19. Herbert, 2014, FindFoci: a focus detection algorithm with automated parameter training that closely matches human assignments, reduces human inconsistencies and increases speed of analysis, PLoS One, 9, 10.1371/journal.pone.0114749 · DOI
  20. Griswold, 2008, Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila, Proc. Natl. Acad. Sci., 105, 8673, 10.1073/pnas.0803837105 · DOI · Paper page
  21. Yang, 2010, Characterization of murine SIRT3 transcript variants and corresponding protein products, J. Cell. Biochem., 111, 1051, 10.1002/jcb.22795 · DOI
  22. Ribeiro, 2013, Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells-protective effect oflcystamine and creatine, Toxicol. Sci., 136, 487, 10.1093/toxsci/kft199 · DOI
  23. Ribeiro, 2014, Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells, Free Radic. Biol. Med., 74, 129, 10.1016/j.freeradbiomed.2014.06.023 · DOI
  24. Willems, 2015, Redox homeostasis and mitochondrial dynamics, Cell Metabol., 22, 207, 10.1016/j.cmet.2015.06.006 · DOI · Paper page
  25. Song, 2011, Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity, Nat. Med., 17, 377, 10.1038/nm.2313 · DOI · Paper page
  26. Zhang, 2020, Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation, Neural Regen. Res., 15, 2143, 10.4103/1673-5374.282264 · DOI
  27. Kurundkar, 2019, SIRT3 diminishes inflammation and mitigates endotoxin-induced acute lung injury, JCI Insight, 4, 10.1172/jci.insight.120722 · DOI · Paper page
  28. Green, 2012, Choosing and using Drosophila models to characterize modifiers of Huntington's disease, Biochem. Soc. Trans., 40, 739, 10.1042/BST20120072 · DOI
  29. Shehadeh, 2006, Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease, Neurobiol. Dis., 21, 392, 10.1016/j.nbd.2005.08.001 · DOI · Paper page
  30. Ferreira, 2011, Bioenergetic dysfunction in Huntington's disease human cybrids, Exp. Neurol., 231, 127, 10.1016/j.expneurol.2011.05.024 · DOI
  31. Silva, 2013, Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic huntington's disease carriers, Mitochondrion, 13, 801, 10.1016/j.mito.2013.05.006 · DOI
  32. Jeong, 2012, Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway, Nat. Med., 18, 159, 10.1038/nm.2559 · DOI · Paper page
  33. Jiang, 2012, Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets, Nat. Med., 18, 153, 10.1038/nm.2558 · DOI · Paper page
  34. Hong, 2015, Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease, Brain, 138, 3030, 10.1093/brain/awv188 · DOI
  35. Cieślik, 2015, The molecular mechanism of amyloid β42 peptide toxicity: the role of sphingosine kinase-1 and mitochondrial sirtuins, PLoS One, 10, 10.1371/journal.pone.0137193 · DOI
  36. Kim, 2011, Neuronal sirt3 protects against excitotoxic injury in mouse cortical neuron culture, PLoS One, 6
  37. Ribeiro, 2012, Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells, Free Radic. Biol. Med., 53, 1857, 10.1016/j.freeradbiomed.2012.09.004 · DOI
  38. Howitz, 2003, Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 425, 191, 10.1038/nature01960 · DOI · Paper page
  39. Rardin, 2013, Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways, Proc. Natl. Acad. Sci., 110, 6601, 10.1073/pnas.1302961110 · DOI · Paper page
  40. Liot, 2009, Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway, Cell Death Differ., 16, 899, 10.1038/cdd.2009.22 · DOI · Paper page
  41. Bleazard, 1999, The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast, Nat. Cell Biol., 1, 298, 10.1038/13014 · DOI · Paper page
  42. Haun, 2013, S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in huntington's disease, Antioxidants Redox Signal., 19, 1173, 10.1089/ars.2012.4928 · DOI · Paper page
  43. Kim, 2018, Redox regulation of mitochondrial fission protein Drp1 by protein disulfide isomerase limits endothelial senescence, Cell Rep., 23, 3565, 10.1016/j.celrep.2018.05.054 · DOI · Paper page
  44. Morigi, 2015, Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury, J. Clin. Invest., 125, 715, 10.1172/JCI77632 · DOI · Paper page
  45. Hu, 2019, Increased Drp1 acetylation mediates lipid overload-induced cardiomyocyte death and heart dysfunction, Circ. Res., 125, 10.1161/res.125.suppl_1.279 · doi:10.1161/res.125.suppl_1.279
  46. Zhao, 2016, Protective effect of trans-δ-viniferin against high glucose-induced oxidative stress in human umbilical vein endothelial cells through the SIRT1 pathway, Free Radic. Res., 50, 68, 10.3109/10715762.2015.1108412 · DOI

Cited by

See all 75

Metadata

Authors
Naia, L., Carmo, C., Campesan, S., Fão, L., Cotton, V. E., Valero, J., Lopes, C., Rosenstock, T. R., Giorgini, F., & Rego, A. C.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2021-02
Volume
163
Pages
163-179
ISSN
0891-5849 (ISSN-L)
OpenAlex
W3107063347
Cited by
75
References
17
FWCI
4.39
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Fundação Luso-Americana para o Desenvolvimento (SFRH/BD/86655/2012)
  • Medical Research Council (MR/M013847/1)
  • Fundação para a Ciência e a Tecnologia (EXPL/BIM-MEC/2220/2013)
  • European Regional Development Fund (UIDB/04539/2020, POCI-01-0145-FEDER-007440)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2020.11.031
The paper
Naia, L., Carmo, C., Campesan, S., Fão, L., Cotton, V. E., Valero, J., Lopes, C., Rosenstock, T. R., Giorgini, F., & Rego, A. C. (2021). Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2020.11.031

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.